Kearkiat Praditpornsilpa Selected Research

Erythropoietin

12/2023	HLA-B46:01:01:01 and HLA-DRB109:01:02:01 are associated with anti-rHuEPO-induced pure red cell aplasia.
5/2023	The impacts of hypoxia-inducible factor stabilizers on laboratory parameters and clinical outcomes in chronic kidney disease patients with renal anemia: a systematic review and meta-analysis.
1/2020	Effect of Maintenance Intravenous Iron Treatment on Erythropoietin Dose in Chronic Hemodialysis Patients: A Multicenter Randomized Controlled Trial.
5/2014	How bio-questionable are the different recombinant human erythropoietin copy products in Thailand?
5/2014	Rechallenge with intravenous recombinant human erythropoietin can be successful following the treatment of anti-recombinant erythropoietin associated pure red cell aplasia.
7/2011	Biosimilar recombinant human erythropoietin induces the production of neutralizing antibodies.
10/2008	Erythropoietin and its non-erythropoietic derivative: do they ameliorate renal tubulointerstitial injury in ureteral obstruction?
3/2005	Recovery from anti-recombinant-human-erythropoietin associated pure red cell aplasia in end-stage renal disease patients after renal transplantation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kearkiat Praditpornsilpa Research Topics

Disease

23	Chronic Renal Insufficiency 12/2023 - 05/2009
12	Acute Kidney Injury (Acute Renal Failure) 10/2021 - 10/2011
11	Chronic Kidney Failure (Chronic Renal Failure) 01/2022 - 03/2005
6	Pure Red-Cell Aplasia 12/2023 - 03/2005
6	Vascular Calcification 05/2023 - 01/2017
6	Infections 12/2022 - 09/2011
6	Proteinuria 01/2022 - 05/2014
5	Anemia 12/2023 - 05/2009
4	Leptospirosis 01/2023 - 08/2006
4	Cardiovascular Diseases (Cardiovascular Disease) 02/2022 - 12/2018
4	Body Weight (Weight, Body) 01/2022 - 02/2009
4	Fibrosis (Cirrhosis) 01/2022 - 08/2006
4	Sepsis (Septicemia) 01/2020 - 10/2013
4	Peritonitis 01/2020 - 07/2016
4	Critical Illness (Critically Ill) 01/2020 - 12/2011
3	Albuminuria 11/2023 - 12/2015
3	IGA Glomerulonephritis (IGA Nephropathy) 01/2023 - 05/2014
3	Chronic Kidney Disease-Mineral and Bone Disorder (Renal Rickets) 05/2022 - 01/2018
3	Hyperphosphatemia 05/2022 - 01/2021
3	Secondary Hyperparathyroidism 02/2022 - 11/2019
3	Inflammation (Inflammations) 01/2022 - 08/2006
3	Kidney Diseases (Kidney Disease) 11/2021 - 01/2020
2	COVID-19 10/2021 - 12/2020
2	Hemorrhage 01/2021 - 01/2021
2	Thrombocytopenia (Thrombopenia) 04/2020 - 01/2020
2	Tachypnea 04/2020 - 01/2020
2	Hepatitis B 04/2020 - 01/2019
2	Hypotension (Low Blood Pressure) 12/2018 - 06/2015
2	Nausea 01/2018 - 08/2006
2	Flushing 07/2016 - 08/2006
1	Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal) 02/2024
1	Hypertension (High Blood Pressure) 02/2024
1	Neoplasms (Cancer) 12/2023
1	Mental Disorders (Mental Disorder) 12/2023
1	Diabetic Nephropathies (Diabetic Nephropathy) 11/2023
1	Vitamin K Deficiency 05/2023
1	Hypoxia (Hypoxemia) 05/2023
1	Thrombotic Microangiopathies 01/2023

Drug/Important Bio-Agent (IBA)

9	Proteins (Proteins, Gene)FDA Link 01/2022 - 08/2006
8	Erythropoietin FDA Link 12/2023 - 03/2005
8	Biomarkers (Surrogate Marker)IBA 05/2022 - 06/2013
7	CreatinineIBA 01/2022 - 12/2015
4	IndicanIBA 01/2022 - 01/2021
4	Lipocalin-2IBA 02/2018 - 06/2013
3	Phosphates (Orthophosphate)IBA 01/2023 - 03/2022
3	MineralsIBA 05/2022 - 01/2018
3	AntigensIBA 01/2022 - 01/2019
3	Uremic ToxinsIBA 01/2022 - 01/2021
3	Cinacalcet (Sensipar)FDA Link 01/2021 - 01/2018
3	NitrogenIBA 04/2020 - 02/2009
3	Hemoglobins (Hemoglobin)IBA 04/2020 - 10/2008
3	Ceftazidime (Fortum)FDA LinkGeneric 01/2020 - 03/2017
3	Cefazolin (Ancef)FDA LinkGeneric 01/2020 - 03/2017
3	CytokinesIBA 06/2015 - 12/2011
2	Glucose (Dextrose)FDA LinkGeneric 02/2024 - 11/2023
2	Ferritins (Ferritin)IBA 05/2023 - 01/2020
2	IronIBA 05/2023 - 01/2020
2	Immunosuppressive Agents (Immunosuppressants)IBA 11/2022 - 08/2006
2	Fibroblast Growth Factor-23IBA 02/2022 - 01/2018
2	Serum AlbuminIBA 01/2022 - 01/2016
2	Sulfates (Sulfates, Inorganic)IBA 12/2021 - 01/2021
2	Insulin (Novolin)FDA Link 07/2021 - 09/2020
2	AnticoagulantsIBA 01/2021 - 12/2011
2	Vitamin K FDA Link 01/2021 - 01/2017
2	Urea (Carbamide)FDA LinkGeneric 04/2020 - 01/2020
2	HLA Antigens (Human Leukocyte Antigens)IBA 04/2020 - 10/2018
2	VaccinesIBA 04/2020 - 10/2019
2	Dialysis SolutionsIBA 01/2020 - 08/2009
2	Bicarbonates (Hydrogen Carbonate)IBA 01/2020 - 06/2015
2	Hepatitis B Surface Antigens (HBsAg)FDA Link 10/2019 - 01/2019
2	sodium thiosulfate FDA Link 02/2019 - 01/2018
2	Furosemide (Lasix)FDA LinkGeneric 01/2019 - 04/2018
2	Tacrolimus (Prograf)FDA LinkGeneric 04/2018 - 01/2018
2	Ergocalciferols (Ergocalciferol)FDA LinkGeneric 01/2017 - 08/2010
2	T-Type Calcium Channels (T-Type Calcium Channel)IBA 12/2015 - 12/2015
2	Citric Acid (Citrate)FDA LinkGeneric 12/2011 - 08/2006
2	Neutralizing AntibodiesIBA 07/2011 - 03/2010
2	AlbuminsIBA 08/2009 - 02/2009
1	CollagenIBA 02/2024
1	ParaffinIBA 02/2024
1	HLA-B Antigens (HLA-B)IBA 12/2023
1	HLA-DRB1*09:01:02 antigenIBA 12/2023
1	CanagliflozinIBA 11/2023
1	SymportersIBA 11/2023
1	SodiumIBA 11/2023
1	HepcidinsIBA 05/2023
1	Immunoglobulin A (IgA)IBA 01/2023

Therapy/Procedure

10	Renal Dialysis (Hemodialysis) 05/2023 - 03/2010
10	Kidney Transplantation 11/2022 - 03/2005
7	Renal Replacement Therapy (Therapies, Renal Replacement) 12/2023 - 09/2011
5	Peritoneal Dialysis 07/2021 - 09/2011
5	Therapeutics 11/2019 - 08/2006
3	Parathyroidectomy 02/2022 - 02/2019
3	Hemodiafiltration 01/2018 - 08/2006
3	Continuous Renal Replacement Therapy 01/2016 - 10/2011
2	Nephrectomy 01/2022 - 08/2006
2	Artificial Respiration (Mechanical Ventilation) 01/2021 - 04/2020
2	Transplantation 01/2021 - 08/2006
2	Continuous Ambulatory Peritoneal Dialysis (CAPD) 11/2019 - 03/2017
2	Subcutaneous Injections 07/2011 - 05/2009